Low-density lipoprotein cholesterol and risk of COPD: Copenhagen General Population Study
Background Randomised controlled trials found that low-density lipoprotein (LDL) cholesterol-lowering statins increase lung function and possibly decrease rate of exacerbations in individuals with COPD. However, it is unknown whether high levels of LDL cholesterol are associated with increased susce...
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
European Respiratory Society
2023-03-01
|
| Edice: | ERJ Open Research |
| On-line přístup: | http://openres.ersjournals.com/content/9/2/00496-2022.full |